230 related articles for article (PubMed ID: 16709031)
1. Use of replication-competent retroviral vectors in an immunocompetent intracranial glioma model.
Wang W; Tai CK; Kershaw AD; Solly SK; Klatzmann D; Kasahara N; Chen TC
Neurosurg Focus; 2006 Apr; 20(4):E25. PubMed ID: 16709031
[TBL] [Abstract][Full Text] [Related]
2. Single-shot, multicycle suicide gene therapy by replication-competent retrovirus vectors achieves long-term survival benefit in experimental glioma.
Tai CK; Wang WJ; Chen TC; Kasahara N
Mol Ther; 2005 Nov; 12(5):842-51. PubMed ID: 16257382
[TBL] [Abstract][Full Text] [Related]
3. Replication-competent retrovirus vector-mediated prodrug activator gene therapy in experimental models of human malignant mesothelioma.
Kawasaki Y; Tamamoto A; Takagi-Kimura M; Maeyama Y; Yamaoka N; Terada N; Okamura H; Kasahara N; Kubo S
Cancer Gene Ther; 2011 Aug; 18(8):571-8. PubMed ID: 21660062
[TBL] [Abstract][Full Text] [Related]
4. VSV-G pseudotyped, MuLV-based, semi-replication-competent retrovirus for cancer treatment.
Qiao J; Moreno J; Sanchez-Perez L; Kottke T; Thompson J; Caruso M; Diaz RM; Vile R
Gene Ther; 2006 Oct; 13(20):1457-70. PubMed ID: 16724095
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic efficacy of replication-competent retrovirus vector-mediated suicide gene therapy in a multifocal colorectal cancer metastasis model.
Hiraoka K; Kimura T; Logg CR; Tai CK; Haga K; Lawson GW; Kasahara N
Cancer Res; 2007 Jun; 67(11):5345-53. PubMed ID: 17545615
[TBL] [Abstract][Full Text] [Related]
6. Highly efficient gene delivery for bladder cancers by intravesically administered replication-competent retroviral vectors.
Kikuchi E; Menendez S; Ozu C; Ohori M; Cordon-Cardo C; Logg CR; Kasahara N; Bochner BH
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4511-8. PubMed ID: 17671137
[TBL] [Abstract][Full Text] [Related]
7. Highly efficient and tumor-restricted gene transfer to malignant gliomas by replication-competent retroviral vectors.
Wang WJ; Tai CK; Kasahara N; Chen TC
Hum Gene Ther; 2003 Jan; 14(2):117-27. PubMed ID: 12614563
[TBL] [Abstract][Full Text] [Related]
8. Comparative evaluation of preclinical in vivo models for the assessment of replicating retroviral vectors for the treatment of glioblastoma.
Hlavaty J; Jandl G; Liszt M; Petznek H; König-Schuster M; Sedlak J; Egerbacher M; Weissenberger J; Salmons B; Günzburg WH; Renner M
J Neurooncol; 2011 Mar; 102(1):59-69. PubMed ID: 20623247
[TBL] [Abstract][Full Text] [Related]
9. Adenovirus-retrovirus hybrid vectors achieve highly enhanced tumor transduction and antitumor efficacy in vivo.
Kubo S; Haga K; Tamamoto A; Palmer DJ; Ng P; Okamura H; Kasahara N
Mol Ther; 2011 Jan; 19(1):76-82. PubMed ID: 20808291
[TBL] [Abstract][Full Text] [Related]
10. Intravenous administration of retroviral replicating vector, Toca 511, demonstrates therapeutic efficacy in orthotopic immune-competent mouse glioma model.
Huang TT; Parab S; Burnett R; Diago O; Ostertag D; Hofman FM; Espinoza FL; Martin B; Ibañez CE; Kasahara N; Gruber HE; Pertschuk D; Jolly DJ; Robbins JM
Hum Gene Ther; 2015 Feb; 26(2):82-93. PubMed ID: 25419577
[TBL] [Abstract][Full Text] [Related]
11. Radiosensitization of gliomas by intracellular generation of 5-fluorouracil potentiates prodrug activator gene therapy with a retroviral replicating vector.
Takahashi M; Valdes G; Hiraoka K; Inagaki A; Kamijima S; Micewicz E; Gruber HE; Robbins JM; Jolly DJ; McBride WH; Iwamoto KS; Kasahara N
Cancer Gene Ther; 2014 Oct; 21(10):405-410. PubMed ID: 25301172
[TBL] [Abstract][Full Text] [Related]
12. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
[TBL] [Abstract][Full Text] [Related]
13. Beyond oncolytic virotherapy: replication-competent retrovirus vectors for selective and stable transduction of tumors.
Dalba C; Klatzmann D; Logg CR; Kasahara N
Curr Gene Ther; 2005 Dec; 5(6):655-67. PubMed ID: 16457654
[TBL] [Abstract][Full Text] [Related]
14. Efficient Prodrug Activator Gene Therapy by Retroviral Replicating Vectors Prolongs Survival in an Immune-Competent Intracerebral Glioma Model.
Chen SH; Sun JM; Chen BM; Lin SC; Chang HF; Collins S; Chang D; Wu SF; Lu YC; Wang W; Chen TC; Kasahara N; Wang HE; Tai CK
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32093290
[TBL] [Abstract][Full Text] [Related]
15. Identification and functional characterization of glioma-specific promoters and their application in suicide gene therapy.
Yawata T; Maeda Y; Okiku M; Ishida E; Ikenaka K; Shimizu K
J Neurooncol; 2011 Sep; 104(2):497-507. PubMed ID: 21347689
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety/toxicity study of recombinant vaccinia virus JX-594 in two immunocompetent animal models of glioma.
Lun X; Chan J; Zhou H; Sun B; Kelly JJ; Stechishin OO; Bell JC; Parato K; Hu K; Vaillant D; Wang J; Liu TC; Breitbach C; Kirn D; Senger DL; Forsyth PA
Mol Ther; 2010 Nov; 18(11):1927-36. PubMed ID: 20808290
[TBL] [Abstract][Full Text] [Related]
17. The antitumor effect of mesenchymal stem cells transduced with a lentiviral vector expressing cytosine deaminase in a rat glioma model.
Fei S; Qi X; Kedong S; Guangchun J; Jian L; Wei Q
J Cancer Res Clin Oncol; 2012 Feb; 138(2):347-57. PubMed ID: 22139383
[TBL] [Abstract][Full Text] [Related]
18. Antitumor efficiency of the cytosine deaminase/5-fluorocytosine suicide gene therapy system on malignant gliomas: an in vivo study.
Lv SQ; Zhang KB; Zhang EE; Gao FY; Yin CL; Huang CJ; He JQ; Yang H
Med Sci Monit; 2009 Jan; 15(1):BR13-20. PubMed ID: 19114960
[TBL] [Abstract][Full Text] [Related]
19. Regression of advanced rat and human gliomas by local or systemic treatment with oncolytic parvovirus H-1 in rat models.
Geletneky K; Kiprianova I; Ayache A; Koch R; Herrero Y Calle M; Deleu L; Sommer C; Thomas N; Rommelaere J; Schlehofer JR
Neuro Oncol; 2010 Aug; 12(8):804-14. PubMed ID: 20299703
[TBL] [Abstract][Full Text] [Related]
20. Brain tumor eradication and prolonged survival from intratumoral conversion of 5-fluorocytosine to 5-fluorouracil using a nonlytic retroviral replicating vector.
Ostertag D; Amundson KK; Lopez Espinoza F; Martin B; Buckley T; Galvão da Silva AP; Lin AH; Valenta DT; Perez OD; Ibañez CE; Chen CI; Pettersson PL; Burnett R; Daublebsky V; Hlavaty J; Gunzburg W; Kasahara N; Gruber HE; Jolly DJ; Robbins JM
Neuro Oncol; 2012 Feb; 14(2):145-59. PubMed ID: 22070930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
